GRAL
GRAILDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
GRAL vs peer average
32/100
GRAL vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 4 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ARQT is the first available peer comparator.
Arcutis is a loose same-cap biotech comparator from the packet, but not a direct multi-cancer early detection peer; GRAL should trade more on Galleri-specific regulatory and commercialization milestones than broad biotech beta.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GRAL
GRAIL
ARQT
Arcutis Biotherapeutics
Grade
D
B
Momentum
62
82
Value
41
49
Sentiment
35
44
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ARQT
GRAL / ARQT
Grade Position
Below peers
GRAL vs. peer average (D vs. C)
32/100
Momentum
62
ARQTValue
41
ARQTSentiment
35
ARQTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GRAL
ARQT is the first peer returned for this comparison set.